Clinical Next Gen Sequencing Dry Lab Service

SOPHiA GENETICS is at the forefront of integrating artificial intelligence (AI) and machine learning (ML) into healthcare through its SOPHiA DDM™ platform. This cloud-based analytics solution is designed to standardize, compute, and analyze complex multimodal healthcare data, enabling healthcare professionals to derive actionable insights that can enhance patient outcomes. The platform supports a wide range of applications, including genomic profiling and liquid biopsy analysis, allowing institutions to retain ownership of their data while collaborating within a global network of over 780 healthcare institutions across more than 70 countries. The SOPHiA DDM™ platform is continually evolving, improving its capabilities as more data is analyzed, thereby advancing precision medicine across various disease areas, particularly oncology and inherited disorders.

In addition to its core platform, SOPHiA GENETICS has developed specialized solutions such as the SOPHiA DDM™ HRD Solution, which focuses on identifying homologous recombination deficiency (HRD) in ovarian cancers by analyzing both germline and somatic mutations. The company also offers CUMIN™, a unique molecular identifier technology that enhances the sensitivity and accuracy of liquid biopsy analyses. By leveraging advanced algorithms and a collaborative approach, SOPHiA GENETICS aims to streamline the adoption of precision medicine, making it more accessible and effective for healthcare providers and patients alike. Their partnerships with leading institutions, such as Memorial Sloan Kettering Cancer Center, further bolster their commitment to advancing cancer research and treatment through innovative data-driven solutions.

Switzerland

SOPHiA GENETICS is a healthcare company that specializes in genomics analysis using artificial intelligence and data analysis.

Sophia Genetics

Company Details